VOYA Investment Management
SRNE

VOYA Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

VOYA Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-185,246
Closed -$164K – 2960
2022
Q4 		$164K Buy
185,246
+35,002
+23% +$46.4K ﹤0.01% 2633
2022
Q3 		$236K Buy
150,244
+6,279
+4% +$14.2K ﹤0.01% 2496
2022
Q2 		$289K Buy
143,965
+29,510
+26% +$51K ﹤0.01% 2193
2022
Q1 		$267K Buy
114,455
+5,824
+5% +$18.2K ﹤0.01% 2225
2021
Q4 		$505K Buy
108,631
+1,092
+1% +$6.78K ﹤0.01% 2006
2021
Q3 		$821K Hold
107,539
– – ﹤0.01% 1715
2021
Q2 		$1.04M Sell
107,539
-2,029
-2% -$16.2K ﹤0.01% 1597
2021
Q1 		$906K Buy
109,568
+2,671
+2% +$28.2K ﹤0.01% 1658
2020
Q4 		$730K Buy
106,897
+31,837
+42% +$256K ﹤0.01% 1679
2020
Q3 		$837K Buy
75,060
+14,805
+25% +$135K ﹤0.01% 1380
2020
Q2 		$378K Sell
60,255
-6,913
-10% -$26.5K ﹤0.01% 1831
2020
Q1 		$124K Buy
67,168
+5,950
+10% +$17.1K ﹤0.01% 2291
2019
Q4 		$207K Buy
61,218
+11,074
+22% +$26.4K ﹤0.01% 2360
2019
Q3 		$107K Hold
50,144
– – ﹤0.01% 2396
2019
Q2 		$134K Buy
50,144
+3,414
+7% +$12.3K ﹤0.01% 2393
2019
Q1 		$222K Hold
46,730
– – ﹤0.01% 2219
2018
Q4 		$112K Buy
46,730
+4,735
+11% +$15.5K ﹤0.01% 2377
2018
Q3 		$185K Buy
41,995
+8,237
+24% +$45.7K ﹤0.01% 2363
2018
Q2 		$243K Buy
+33,758
New +$230K ﹤0.01% 2270
2017
Q2 		– Sell
-14,911
Closed -$59K – 2663
2017
Q1 		$59K Hold
14,911
– – ﹤0.01% 2475
2016
Q4 		$73K Hold
14,911
– – ﹤0.01% 2485
2016
Q3 		$115K Hold
14,911
– – ﹤0.01% 2448
2016
Q2 		$84K Hold
14,911
– – ﹤0.01% 2502
2016
Q1 		$80K Hold
14,911
– – ﹤0.01% 2436
2015
Q4 		$130K Hold
14,911
– – ﹤0.01% 2421
2015
Q3 		$125K Hold
14,911
– – ﹤0.01% 2436
2015
Q2 		$263K Buy
+14,911
New +$192K ﹤0.01% 2344

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

VOYA Investment Management's SRNE Position: Q1 2023 in Review

VOYA Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 185,246 shares — an estimated $164K sold.

VOYA Investment Management first reported a position in SRNE in Q2 2015 and held it in 27 quarters. The position peaked at $1.04M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • VOYA Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • VOYA Investment Management sold 185,246 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $164K.
  • VOYA Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 27 quarters.
  • VOYA Investment Management's Sorrento Therapeutics, Inc. position peaked at $1.04M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on VOYA Investment Management's 13F filing for Q1 2023, filed 15 May 2023.